ENDAVA (NYSE: DAVA) Replaces CEO and CFO, Confirms Financial Statements Are Unreliable, Contracts Lack Economic Substance, Financial Restatements Pending - Hagens Berman

Stock Information for Anavex Life Sciences Corp.

Loading

Please wait while we load your information from QuoteMedia.